These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1431014)

  • 21. The safety profile of paroxetine.
    Boyer WF; Blumhardt CL
    J Clin Psychiatry; 1992 Feb; 53 Suppl():61-6. PubMed ID: 1531828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 12-week double-blind multi-centre study of paroxetine and imipramine in hospitalized depressed patients.
    Arminen SL; Ikonen U; Pulkkinen P; Leinonen E; Mahlanen A; Koponen H; Kourula K; Ryyppö J; Korpela V; Lehtonen ML
    Acta Psychiatr Scand; 1994 Jun; 89(6):382-9. PubMed ID: 8085467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients.
    Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM;
    Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paroxetine versus placebo: a double-blind comparison in depressed patients.
    Claghorn JL; Kiev A; Rickels K; Smith WT; Dunbar GC
    J Clin Psychiatry; 1992 Dec; 53(12):434-8. PubMed ID: 1487471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Paroxetine: a review of clinical experience.
    Dunner D; Kumar R
    Pharmacopsychiatry; 1998 May; 31(3):89-101. PubMed ID: 9657236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An overview of paroxetine in the elderly.
    Dunner DL
    Gerontology; 1994; 40 Suppl 1():21-7. PubMed ID: 8020767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability.
    Rechlin T
    J Clin Psychopharmacol; 1994 Dec; 14(6):392-5. PubMed ID: 7884019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of the psychomotor effects of paroxetine.
    Hawley CJ; McPhee S; Quick SJ; Smith VR
    Int Clin Psychopharmacol; 1997 Jan; 12(1):13-8. PubMed ID: 9179629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of paroxetine, imipramine and placebo in depressed outpatients.
    Feighner JP
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():31-5. PubMed ID: 1431008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A double-blind comparative study of the effectiveness and tolerance of paroxetine and amitriptyline in treatment of breast cancer patients with clinically assessed depression].
    Möslinger-Gehmayr R; Zaninelli R; Contu A; Oberhoff C; Gutschow K; Schindler AE; Staab HJ
    Zentralbl Gynakol; 2000; 122(4):195-202. PubMed ID: 10795116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term treatment of major depressive disorder with paroxetine.
    Duboff EA
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):28S-33S. PubMed ID: 8106653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A; Feiger A
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacodynamics of milnacipran in young and elderly volunteers.
    Hindmarch I; Rigney U; Stanley N; Briley M
    Br J Clin Pharmacol; 2000 Feb; 49(2):118-25. PubMed ID: 10671905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Misdiagnosis of antidepressant discontinuation symptoms.
    Haddad PM; Qureshi M
    Acta Psychiatr Scand; 2000 Dec; 102(6):466-7; discussion 467-8. PubMed ID: 11142438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.
    Schöne W; Ludwig M
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):34S-39S. PubMed ID: 8106654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
    Schöne W; Ludwig M
    Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind comparison of paroxetine and placebo in the treatment of depressed outpatients.
    Claghorn J
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 4():25-30. PubMed ID: 1431007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal after discontinuation of paroxetine.
    Arya DK
    Aust N Z J Psychiatry; 1996 Oct; 30(5):702. PubMed ID: 8902183
    [No Abstract]   [Full Text] [Related]  

  • 39. Antidepressants and driver impairment: empirical evidence from a standard on-the-road test.
    Ramaekers JG
    J Clin Psychiatry; 2003 Jan; 64(1):20-9. PubMed ID: 12590619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adverse effects: priapism caused by paroxetine].
    Bertholon F; Krajewski Y; el Allali A
    Ann Med Psychol (Paris); 1996 May; 154(2):145-6; discussion 146-7. PubMed ID: 8694403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.